Maintenance Therapy in AML

NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa2004444

Author: Dr. Danyal Ladha, University of Ottawa
Reviewer: Dr. Hassan Sibai, University of Toronto

Objectives

At the end of the self-assessment module, participants will be able to:
1. Describe the role of maintenance therapy in the post-remission management of AML
2. Define the mechanism of action and clinical efficacy for an approved agent regarding maintenance therapy in AML
3. Recite the safety data and overall health related quality of life associated with maintenance therapy in AML

CHS Scientific Planning Committee Members (2021-22)

Dr. Joanne Britto – Resident Physician, Hematology-Oncology
Dr. Yan Xu – Fellow Physician, Hematology
Dr. Siraj Mithoowani – Clinical Hematologist at St. Joseph’s Healthcare, Hamilton
Dr. Hassan Sibai – Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician, Division of Medical Hematology & Oncology, Princess Margaret Cancer Centre

Conflicts of Interest: None